Zhi-Hong Chen Selected Research

Zhi-Hong Chen Research Topics

Disease

29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2008
23	Neoplasms (Cancer) 01/2022 - 09/2007
14	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2007
6	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2008
4	Adenocarcinoma of Lung 01/2018 - 06/2011
2	Epilepsy (Aura) 03/2022 - 01/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 07/2019
2	Hemorrhage 12/2021 - 09/2013
2	Sarcoma (Soft Tissue Sarcoma) 12/2019 - 07/2014
2	Carcinoma (Carcinomatosis) 07/2019 - 09/2007
2	Carcinogenesis 01/2016 - 08/2012
1	Wilms Tumor (Wilm's Tumor) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Papillomavirus Infections 01/2022
1	Urinary Retention 12/2021
1	Colic (Abdominal Cramps) 12/2021
1	Pathologic Constriction (Stenosis) 12/2021
1	AIDS-Related Complex (ARC) 12/2021
1	Rectal Neoplasms (Rectal Cancer) 12/2021
1	Postoperative Hemorrhage 12/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 02/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2021
1	Virilism (Virilization) 11/2020
1	Asthma (Bronchial Asthma) 09/2020
1	Inflammation (Inflammations) 09/2020
1	Squamous Cell Carcinoma of Head and Neck 08/2020
1	Plasma Cell Granuloma 12/2019
1	Disease Progression 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2017
1	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 10/2017
1	Seizures (Absence Seizure) 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015

Drug/Important Bio-Agent (IBA)

16	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2009
16	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2009
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
8	Messenger RNA (mRNA)IBA 01/2020 - 09/2007
6	Gefitinib (Iressa)FDA Link 01/2016 - 01/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2009
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2007
3	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2013
3	Anaplastic Lymphoma KinaseIBA 01/2020 - 10/2016
2	Biological ProductsIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 08/2020
2	B7-H1 AntigenIBA 01/2022 - 11/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Insulin (Novolin)FDA Link 02/2021 - 01/2015
2	Pharmaceutical PreparationsIBA 09/2020 - 01/2013
2	Sericins (Sericin)IBA 01/2015 - 02/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2015 - 02/2011
2	Blood Glucose (Blood Sugar)IBA 01/2015 - 02/2011
2	CyclinsIBA 01/2013 - 12/2008
2	Aquaporin 5IBA 11/2011 - 06/2011
2	MucinsIBA 11/2011 - 06/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2011 - 01/2011
2	Phosphotransferases (Kinase)IBA 05/2009 - 09/2007
1	Levetiracetam (Keppra)FDA LinkGeneric 03/2022
1	Sincalide FDA Link 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	NucleotidesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2021
1	Dacarbazine (DIC)FDA LinkGeneric 11/2020
1	OvalbuminIBA 09/2020
1	Monocyte Chemoattractant ProteinsIBA 09/2020
1	InterleukinsIBA 09/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 09/2020
1	LuciferasesIBA 09/2020
1	Lithium ChlorideIBA 09/2020
1	Protons (Proton)IBA 07/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Cyclin A2IBA 07/2019
1	abivertinibIBA 05/2019
1	osimertinibIBA 01/2018
1	CrizotinibIBA 01/2018
1	Complementary DNA (cDNA)IBA 12/2017
1	Carrier Proteins (Binding Protein)IBA 10/2017
1	IGF-I-IGFBP-3 complex FDA Link 06/2017
1	piperineIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2016
1	ilepcimideIBA 01/2016
1	Cell-Free Nucleic AcidsIBA 01/2016
1	Adiponectin ReceptorsIBA 07/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2015
1	Growth Hormone (Somatotropin)IBA 01/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2007
4	Drug Therapy (Chemotherapy) 06/2012 - 03/2010
2	Immunotherapy 01/2022 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 12/2019
1	Ambulatory Care (Outpatient Care) 03/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Length of Stay 12/2021
1	Ligation 12/2021
1	Glycemic Control 02/2021
1	Hepatectomy 12/2019
1	Lasers (Laser) 06/2017
1	Intraperitoneal Injections 01/2015